RU2016136449A3 - - Google Patents
Download PDFInfo
- Publication number
- RU2016136449A3 RU2016136449A3 RU2016136449A RU2016136449A RU2016136449A3 RU 2016136449 A3 RU2016136449 A3 RU 2016136449A3 RU 2016136449 A RU2016136449 A RU 2016136449A RU 2016136449 A RU2016136449 A RU 2016136449A RU 2016136449 A3 RU2016136449 A3 RU 2016136449A3
- Authority
- RU
- Russia
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/12—Mucolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Otolaryngology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1403630.5 | 2014-02-28 | ||
| GB201403630A GB201403630D0 (en) | 2014-02-28 | 2014-02-28 | Treatment of cystic fibrosis with alginate oligomers |
| GB201502110A GB201502110D0 (en) | 2015-02-09 | 2015-02-09 | Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective CFTR ion channel function |
| GB1502110.8 | 2015-02-09 | ||
| PCT/EP2015/054207 WO2015128495A1 (en) | 2014-02-28 | 2015-02-27 | Use of alginate oligomers in the treatment of cystic fibrosis and other conditions associated with defective cftr ion channel function |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2016136449A RU2016136449A (ru) | 2018-04-02 |
| RU2016136449A3 true RU2016136449A3 (ru) | 2018-10-19 |
Family
ID=52630347
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2016136449A RU2016136449A (ru) | 2014-02-28 | 2015-02-27 | Применение олигометов альгината в лечении муковисцидоза и других состояний, ассоциированных с нарушенной функцией ионных каналов cftr |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20160361342A1 (ru) |
| EP (1) | EP3110426A1 (ru) |
| JP (1) | JP2017510563A (ru) |
| KR (1) | KR20160119259A (ru) |
| CN (1) | CN106029079A (ru) |
| AU (1) | AU2015222051A1 (ru) |
| CA (1) | CA2940560A1 (ru) |
| RU (1) | RU2016136449A (ru) |
| WO (1) | WO2015128495A1 (ru) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201415381D0 (en) | 2014-08-29 | 2014-10-15 | Algipharma As | Inhalable powder formulations of alginate oligomers |
| GB201504878D0 (en) | 2015-03-23 | 2015-05-06 | Algipharma As | Use of alginate oligomers and CFTR modulators in the treatment of conditions associated with CFTR dysfuntion |
| GB201517639D0 (en) | 2015-10-06 | 2015-11-18 | Algipharma As | Use of alginate oligomers to treat or prevent microbial overgrowth in the intestinal tract |
| EP3565848A4 (en) | 2017-01-03 | 2020-09-02 | The University of North Carolina at Chapel Hill | NITROGEN OXIDE RELEASING ALGINATES AS BIODEGRADABLE ANTIBACTERIAL SCAFFOLDINGS AND ASSOCIATED PROCESSES |
| GB201702161D0 (en) * | 2017-02-09 | 2017-03-29 | Algipharma As | A companion diagnostic method for use in the treatment of cystic fibrosis with alginate oligomers |
| EP3600338A4 (en) | 2017-03-28 | 2020-10-28 | The University of North Carolina at Chapel Hill | NITRIC OXIDE RELEASING POLYAMINOGLYCOSIDES AS BIODEGRADABLE ANTIBACTERIAL SCAFFOLDS AND RELATED PROCESSES |
| JP7565588B2 (ja) | 2018-03-06 | 2024-10-11 | ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒル | 生分解性の抗菌性足場としての一酸化窒素放出性シクロデキストリンおよびそれに関する方法 |
| JP7354132B2 (ja) * | 2018-03-19 | 2023-10-02 | アルギファルマ エーエス | マイクロ粒子／ナノ粒子が粘液層を通って移動するのを強化するためのアルギネートオリゴマーの使用 |
| US11541105B2 (en) | 2018-06-01 | 2023-01-03 | The Research Foundation For The State University Of New York | Compositions and methods for disrupting biofilm formation and maintenance |
| GB201812473D0 (en) | 2018-07-31 | 2018-09-12 | Algipharma As | Method for the qualitative and quantitative detection of alginate oligomers in body fluids |
| EP3902841A4 (en) | 2018-12-28 | 2022-09-28 | The University of North Carolina at Chapel Hill | NITRIC OXIDE RELEASING ANTIBACTERIAL POLYMERS AND SCAFFOLDS MADE THEREOF AND METHODS RELATED THEREOF |
| WO2022079209A1 (en) * | 2020-10-15 | 2022-04-21 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Tg2 inhibitors for improving mucociliary clearance in respiratory diseases |
| CN113603808B (zh) * | 2021-08-10 | 2023-03-31 | 山东省科学院生物研究所 | 改性褐藻胶及制备方法与其在制备促进胃肠蠕动药物中的应用 |
| CN117838672B (zh) * | 2024-03-07 | 2024-05-10 | 山东第二医科大学 | 一种替米考星/g型褐藻寡糖雾化吸入纳米混悬液及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2430881B (en) * | 2005-10-06 | 2010-10-13 | Ntnu Technology Transfer As | Oligoelectrolyte polyols for the treatment of mucosal hyperviscosity |
| GB0707096D0 (en) * | 2007-04-12 | 2007-05-23 | Ntnu Technology Transfer As | Method |
| RU2527894C2 (ru) * | 2007-11-27 | 2014-09-10 | Альгифарма ИПР АС | Использование альгинатных олигомеров в борьбе с биопленками |
| AU2009246217B2 (en) * | 2008-05-15 | 2013-01-10 | Novartis Ag | Pulmonary delivery of a fluoroquinolone |
| GB0909529D0 (en) * | 2009-06-03 | 2009-07-15 | Algipharma Ipr As | Alginate oligomers for the inhibition of microbial adherence to surfaces |
| JP5202764B2 (ja) * | 2009-06-03 | 2013-06-05 | アルギファルマ エーエス | 細菌における多剤耐性の克服に使用されるアルギネートオリゴマー |
| KR101763195B1 (ko) * | 2011-05-19 | 2017-07-31 | 사바라 인코포레이티드 | 건조 분말 반코마이신 조성물 및 관련 방법 |
-
2015
- 2015-02-27 CA CA2940560A patent/CA2940560A1/en not_active Abandoned
- 2015-02-27 AU AU2015222051A patent/AU2015222051A1/en not_active Abandoned
- 2015-02-27 KR KR1020167026840A patent/KR20160119259A/ko unknown
- 2015-02-27 CN CN201580010273.7A patent/CN106029079A/zh active Pending
- 2015-02-27 US US15/121,671 patent/US20160361342A1/en not_active Abandoned
- 2015-02-27 EP EP15708474.0A patent/EP3110426A1/en not_active Withdrawn
- 2015-02-27 RU RU2016136449A patent/RU2016136449A/ru not_active Application Discontinuation
- 2015-02-27 WO PCT/EP2015/054207 patent/WO2015128495A1/en active Application Filing
- 2015-02-27 JP JP2016554405A patent/JP2017510563A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017510563A (ja) | 2017-04-13 |
| KR20160119259A (ko) | 2016-10-12 |
| US20160361342A1 (en) | 2016-12-15 |
| CN106029079A (zh) | 2016-10-12 |
| RU2016136449A (ru) | 2018-04-02 |
| AU2015222051A1 (en) | 2016-10-13 |
| EP3110426A1 (en) | 2017-01-04 |
| WO2015128495A1 (en) | 2015-09-03 |
| CA2940560A1 (en) | 2015-09-03 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20191216 |